Sofosbuvir for COVID-19 infection: A potential candidate.Indian J Pharmacol. 2020 May-Jun; 52(3):232-233.IJ
Links
MeSH
Pub Type(s)
Letter
Language
eng
PubMed ID
32874010
Citation
Gupta, Rohit, and Puneet Dhamija. "Sofosbuvir for COVID-19 Infection: a Potential Candidate." Indian Journal of Pharmacology, vol. 52, no. 3, 2020, pp. 232-233.
Gupta R, Dhamija P. Sofosbuvir for COVID-19 infection: A potential candidate. Indian J Pharmacol. 2020;52(3):232-233.
Gupta, R., & Dhamija, P. (2020). Sofosbuvir for COVID-19 infection: A potential candidate. Indian Journal of Pharmacology, 52(3), 232-233. https://doi.org/10.4103/ijp.IJP_675_20
Gupta R, Dhamija P. Sofosbuvir for COVID-19 Infection: a Potential Candidate. Indian J Pharmacol. 2020;52(3):232-233. PubMed PMID: 32874010.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR
T1 - Sofosbuvir for COVID-19 infection: A potential candidate.
AU - Gupta,Rohit,
AU - Dhamija,Puneet,
Y1 - 2020/08/04/
PY - 2020/7/13/received
PY - 2020/7/16/revised
PY - 2020/7/24/accepted
PY - 2020/9/3/entrez
PY - 2020/9/3/pubmed
PY - 2020/9/10/medline
SP - 232
EP - 233
JF - Indian journal of pharmacology
JO - Indian J Pharmacol
VL - 52
IS - 3
SN - 1998-3751
UR - https://www.unboundmedicine.com/medline/citation/32874010/Sofosbuvir_for_COVID_19_infection:_A_potential_candidate_
DB - PRIME
DP - Unbound Medicine
ER -
Try the Free App:
